Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 784 | 952 | 393 | 667 | 547 |
| Gross Profit | 784 | 952 | 393 | 667 | 547 |
| Operating Expenses | 1,646 | 1,647 | 1,264 | 362 | 1,681 |
| Operating Income | -862 | -695 | -871 | 305 | -1,134 |
| Interest Expense | 3 | 2 | 2 | 0 | 3 |
| Other Income | 915 | 1,242 | 205 | -222 | 570 |
| Pre-tax Income | 50 | 545 | -668 | 83 | -567 |
| Income Tax | N/A | N/A | -32 | N/A | N/A |
| Net Income Continuous | 50 | 545 | -636 | 114 | -567 |
| Net Income Discontinuous | 102 | 6 | -17 | 138 | -42 |
| Net Income | $152 | $551 | $-653 | $252 | $-609 |
| EPS Basic Total Ops | 0.01 | 0.05 | -0.06 | 0.01 | -0.05 |
| EPS Basic Continuous Ops | 0.00 | 0.05 | -0.06 | 0.01 | -0.05 |
| EPS Basic Discontinuous Ops | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.01 | 0.05 | -0.06 | 0.01 | -0.05 |
| EPS Diluted Continuous Ops | 0.00 | 0.05 | -0.06 | 0.01 | -0.05 |
| EPS Diluted Discontinuous Ops | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.05 | -0.06 | N/A | -0.05 |
| EBITDA(a) | $-766 | $-599 | $-776 | $405 | $-1,038 |